Table 2.
Association between Fli-1 expression and clinicopathological parameters
| Parameter | p-value (uni) | p-value (multi) | 95% CI | OR |
|---|---|---|---|---|
| Age at diagnosis |
0.848 |
0.485 |
0.70-2.13 |
1.22 |
| < 50 vs ≥ 50 | ||||
| FIGO stage |
< 0.010 |
< 0.010 |
0.12-0.52 |
0.25 |
| ≤II vs > II | ||||
| Histological grade |
0.309 |
0.153 |
0.18-1.31 |
0.48 |
| G1 vs G2&G3 | ||||
| Lymph nodal involvement |
0.015 |
< 0.010 |
0.23-0.80 |
0.43 |
| Positive vs negative | ||||
| CA125 serum level |
0.006 |
0.013 |
0.04-0.68 |
0.16 |
| ≤ 35 U/ml vs > 35 U/ml | ||||
| Residual tumor size |
0.341 |
0.421 |
0.41-1.45 |
0.77 |
| 0 mm vs 0-10 mm | ||||
| ER expression |
0.575 |
0.425 |
0.46-1.39 |
0.80 |
| Positive vs negative | ||||
| PR expression |
0.875 |
0.872 |
0.60-1.82 |
1.05 |
| Positive vs negative | ||||
| Her1 expression |
0.228 |
0.230 |
0.80-2.58 |
1.43 |
| Positive vs negative | ||||
| Her2 expression |
0.747 |
0.518 |
0.69-2.08 |
1.20 |
| Positive vs negative | ||||
| P53 expression |
0.586 | 0.836 | 0.59-1.94 | 1.07 |
| Positive vs negative |